These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38098230)

  • 1. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8
    Luan X; Lei T; Fang J; Liu X; Fu H; Li Y; Chu W; Jiang P; Tong C; Qi H; Fu Y
    Mol Ther; 2024 Feb; 32(2):469-489. PubMed ID: 38098230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
    Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
    Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity.
    He N; Huang H; Wu S; Ji W; Tai Y; Gao R; Liu Y; Liu Y; Chen L; Zhu D; Zheng X; Jiang J
    Cancer Sci; 2024 Jul; 115(7):2196-2208. PubMed ID: 38655660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy.
    Wang Y; Zhang H; He YW
    Front Immunol; 2019; 10():1574. PubMed ID: 31379815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
    Marcovecchio PM; Thomas G; Salek-Ardakani S
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
    Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8
    Kim SH; Cho BH; Kim KS; Jang YS
    Cell Rep; 2021 Apr; 35(2):108995. PubMed ID: 33852847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M1
    Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer.
    Yuan M; Wang C; Wu Y; Qiao L; Deng G; Liang N; Chen F; Liu L; Chen Y; Yang Y; Wang H; Liu T; Yang X; Zhang Y; Lv Y; Suwinski R; Hu P; Zhang Y; Zhang J
    Transl Lung Cancer Res; 2023 May; 12(5):1093-1107. PubMed ID: 37323177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
    Imamura R; Kitagawa S; Kubo T; Irie A; Kariu T; Yoneda M; Kamba T; Imamura T
    Prostate; 2021 Feb; 81(3):147-156. PubMed ID: 33368414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype.
    Enbergs N; Halabi EA; Goubet AG; Schleyer K; Fredrich IR; Kohler RH; Garris CS; Pittet MJ; Weissleder R
    Adv Sci (Weinh); 2024 Apr; 11(15):e2309026. PubMed ID: 38342608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
    Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
    Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
    Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 May; ():. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of DC-SIGN
    Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
    Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
    Zhang P; Gu Y; Wang J; Lv K; Lin C; Zhang H; Li H; He H; Li R; Liu H; Xu J
    Int J Cancer; 2023 Jul; 153(1):224-237. PubMed ID: 36799619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
    Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
    Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.